(S)-2-Amino-3-(4-hydroxyphenyl)propanamide, 95.0%, 10g

4-Bromo-2-nitrobenzoic Acid>98.0%(T)5g

ethyl 6-(4-nitrophenyl)-6-oxohexanoate, 97.0%, 1g

2-(2-bromophenyl)-1,3-benzoxazole, 95.0%, 5g

Ethyl 3-(4-(hydroxymethyl)phenyl)propanoate, 95.0%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)-2-methylpropanoic acid, 95%, 50mg

Phosphate monosodique de sodium, min 98%, ultra pur, anhydre, 100 g, emballage plastique.

Carbonate de lutétium hydraté 99,9% 5 g

ethyl 5,5,5-trifluoro-3-oxopentanoate, 96%, 500mg

Benzenesulfonamide, 4-amino-N-(aminoiminomethyl)-, 98%, 100g

Methyl 3'-hydroxy-[1,1'-biphenyl]-4-carboxylate, 97+%, 1g

N2-Acetyl acyclovir, 98%, 100mg

5-nitropyridine-2-thiol, 97.0%, 25g